Official Journal of the Society

Nucleic Acid Therapeutics is the Official Journal of the OTS. It is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines nucleic acids as therapeutic agents or modifying nucleic acids for therapeutic purposes including: single and double stranded oligonucleotides, oligonucleotide chemistry, gene modification, aptamers, RNA nanoparticles, and ribozymes.

It welcomes research papers and reviews, but also commentaries on recent oligonucleotide therapeutic developments. OTS members can access the Journal via the member website, and we encourage members to submit their work to the Journal and to recommend the Journal to their library or institution to facilitate collaboration with colleagues. We highly value input from our members and invite you to reach out to us at info@oligotherapeutics.org. We also welcome suggestions for special issues focusing on a specific approach, disease field or development stage.

The Journal is led by Co-Editors-in-Chief Bruce A. Sullenger, PhD and Annemieke Aartsma-Rus, PhD, Executive Editor Graham Parker, PhD, Senior Editors David Corey, PhD, Mark Kay, MD, PhD and Brett Monia, PhD, European Editor Jens Kurreck, PhD and Asian Editor Dong-ki Lee, PhD and other leading investigators. View the entire editorial board.

Read a free issue of Nucleic Acid Therapeutics online.

Featured Article

  • Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation

Another stellar review article summarizing the field now published in Nucleic Acid Therapeutics. The review in Nucleic Acid Therapeutics by Jillian Belgrad and colleagues discusses the significant progress and future potential of nucleic acid-based therapies (NATs). It highlights the historical milestones, including the approval of over 20 NAT products and hundreds of ongoing clinical trials. The review addresses the major challenges faced by NATs, such as delivery into biological systems, stability, and targeted distribution, while also showcasing the key innovations that are expanding the capabilities of NATs. These advancements are setting the stage for NATs to become a new drug class, offering hope for patients with previously incurable diseases.

  • New Impact Factor: 5.5

    Nucleic Acid Therapeutics announces a new impact factor of 5.486*, a 10% increase over last year! The Journal remains a critical resource for cutting-edge peer-reviewed research on using nucleic acids and related compounds to alter gene expression for therapeutic purposes.

    With an average time to first decision of 17 days, open access publishing options, and accessibility in 170 countries worldwide, publishing with Nucleic Acid Therapeutics ensures your manuscript has the impact and receives the attention it deserves.

    2020 Journal Citation Reports (Clarivate, 2021)

    CiteScore™: 7.5

Paper Submissions

Submit your paper online today! Accepted papers are published online ahead of The Journal features rapid peer review and publication online within 6 weeks of acceptance, and offers Open Access options (with discounts for members). Detailed information and instructions for authors is available online.

Subscription to Nucleic Acid Therapeutics

Nucleic Acid Therapeutics (formerly Oligonucleotides) is the official journal of the OTS. OTS members are entitled to the valuable benefit of a deeply discounted subscription to Nucleic Acid Therapeutics, including access to the full, searchable journal archive.

Become a member of the OTS today to start your discounted subscription to Nucleic Acid Therapeutics!

Already a member?  Login to the online member portal to access your discounted subscription offer to Nucleic Acid Therapeutics.

Recent Publications

President’s Pick Article – July 2024
President’s Pick Article – June 2024
President’s Pick Article – April 2024
Presidents Pick
President’s Pick Article – December 2023
Presidents Pick
President’s Pick Article – August 2023
Presidents Pick
President’s Pick – April 2023
Presidents Pick
President’s Pick – March 27 2023
Presidents Pick
President’s Pick – March 2023
Presidents Pick
OTS President’s Pick Paper – October 2022
Presidents Pick
OTS President’s Pick Paper – September 2022
Presidents Pick
OTS President’s Pick Paper – July 2022
Presidents Pick
OTS President’s Paper Pick – June 2022
President’s Pick of Presentations from the Annual OTS Meeting
OTS President’s Paper Pick – August 2021
OTS President’s Paper Pick– July 2021